☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
EpimAb Biotherapeutics
EpimAb Biotherapeutics and Vignette Bio Partner to Develop EMB-06 for Autoimmune Disorders
September 4, 2024
EpimAb Biotherapeutics Entered into a License Agreement with Almirall to Develop Bispecific Antibody
October 12, 2023
Load more...
Back to Home
Modal title
×
Modal body text goes here.
